Health & Fitness
Tue, January 13, 2009Mon, January 12, 2009Sun, January 11, 2009Fri, January 9, 2009Thu, January 8, 2009Wed, January 7, 2009Tue, January 6, 2009Mon, January 5, 2009Fri, January 2, 2009Thu, January 1, 2009Wed, December 31, 2008Tue, December 30, 2008Mon, December 29, 2008Wed, December 24, 2008Tue, December 23, 2008Mon, December 22, 2008Quidel Corporation to Present at the 27th Annual J.P. Morgan Healthcare Conference
Published in Health and Fitness on Tuesday, January 6th 2009 at 14:29 GMT, Last Modified on 2009-01-06 14:30:30 by Market Wire
SAN DIEGO--([ BUSINESS WIRE ])--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, today announced that it will present at the 27th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco on January 12-15, 2009.
Caren Mason, president and chief executive officer, and John Radak, chief financial officer, will present on Thursday, January 15, 2009 at 3:30 p.m. Eastern time (12:30 p.m. Pacific time).
A webcast and audio archive of the presentation will be available via the Investor Relations section of the Company's Web site at [ www.quidel.com ]. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 90 days.
About Quidel Corporation
Quidel Corporation serves to enhance the health and well being of people around the globe through the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point of care (POC) in infectious diseases and reproductive health. Marketed under the leading brand name of QuickVue®, Quidel's portfolio of products currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, H. pylori and Chlamydia. Quidel's products are sold to healthcare professionals with a focus on the physician office lab and acute care markets through leading medical distribution partners on a worldwide basis. Quidel's Specialty Products Group (SPG) develops research products in the fields of oncology and bone health with potential future point-of-care applications. By building value in rapid diagnostic tests, Quidel provides leadership to the industry and among healthcare professionals allowing for the movement of patient testing out of the central laboratory setting and into the physician office, urgent care and other outpatient settings where rapid testing and treatment has an impact on clinical outcomes and provides an economic benefit. For more information, visit [ www.quidel.com ], [ www.colorectal-test.com ] or [ www.flutest.com ].
